Breaking Scientists Seek Natural Resistance to Revive American Elm Trees Displaced Families in Southern Lebanon Seek Shelter in Schools Ahead of New Academic Year Expert Report Suggests U.S. Missile May Have Caused Civilian Casualties in Iran Japan Plans Major Defense Upgrade Integrating AI, Drones, and New Missiles Hurricane Karina Intensifies to Category 4 in Pacific Ocean

Monday August 31, 2026

Reporter

Ascletis Pharma Inc.

1Articles Published

3Communities Covered

Published Articles

Press Release

Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight Management

Aug 30